RAD54B and prostate cancer: We verified the results in MCF7 cells by determining the effect of RAD54L+RAD54B depletion in two additional cell lines: the prostate cancer cell line, PC-3 and the triple-negative breast cancer cell line, MDAMB231 (Supplementary Figure S5).